secwatch.observer — SEC 8-K summary
======================================

Issuer:     AEON Biopharma, Inc. (AEON)
CIK:        0001837607
Form:       8-K
Filed at:   2026-07-23T20:01:19+00:00
Accession:  0001837607-26-000055
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

AEON Biopharma issues 4.7M shares in partial over-allotment exercise, raising $1.5M gross
--------------------------------------------------------------------------------

- On July 23, 2026, issued 4,696,102 shares of Class A common stock to underwriters.
- Gross proceeds of approximately $1.5 million; net proceeds of ~$1.4 million after underwriting discounts.
- Partial exercise of over-allotment option; previous full exercise for warrants to purchase 6,403,290 shares.
- Offering originally completed July 15, 2026, with Lake Street Capital Markets as representative.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1837607/000183760726000055/0001837607-26-000055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1837607/000183760726000055/aeon-20260723x8k.htm
  HTML page:      https://secwatch.observer/filing/0001837607-26-000055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer